Integrating network pharmacology and experimental models to investigate the efficacy and mechanism of Tiansha mixture on xerosis
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03201-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Yuan Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine pharmacy, Hangzhou Hospital of Traditional Chinese Medicine (Hangzhou TCM Hospital Affiliated to Zhejiang …. Hauptthemen laut MEDLINE: Network Pharmacology, Drugs, Chinese Herbal, Molecular Docking Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Zhejiang Province Traditional Chinese Medicine Science and Technology Project.
Abstract (Originalsprache)
Epidermal Growth Factor Receptor Inhibitors (EGFRIs) is a common cancer therapy, but they occasionally cause severe side effects such as xerosis. Tiansha mixture (TM), a traditional Chinese medicines formulation, is develpoed to treat xerosis. This study aims to understand mechanisms of TM on xerosis. Bio-active compounds were selected from databases (TCMSP, TCM-ID, HERB, ETCM) and removed for poor oral bioavailability and low drug likeness. Then a network-based approach filtered out potential active compounds against xerosis. KEGG enrichment analysis identified PI3K/AKT and ERK/MAPK pathways, which were further verified by molecular docking. Afterwards, the effect of TM on activation of PI3K/AKT and ERK/MAPK pathways was validated in gefitinib-induced xerosis rats, where AKT-activator SC79 and MAPK-activator CrPic were also applied. Skin damage was assessed by dorsal score and HE and Tunel stainings. the levels of inflammation factors IL-6 and TNF-α in serum and skin tissue were measured by ELISA. Western blot was used to detect protein levels in the pathways. Network pharmacology identified 111 bio-active compounds from TM and 14 potential targets. Docking simulation showed apigenin, luteolin, and quercetin bio-active compounds in TM bound to IKBKG, INSR, and RAF-1 proteins. In xerosis model rats, TM mitigated xerosis damage, decreased inflammation factors, and phosphorylation of PI3K/AKT and ERK/MAPK proteins. SC79 or CrPic or their combination reversed TM's effect. The current study identified potential targets and PI3K/AKT and ERK/MAPK pathways involved in the effect of TM on xerosis, thus providing a foundation for TM clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine pharmacy, Hangzhou Hospital of Traditional Chinese Medicine (Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, No. 453 Stadium Road, Xihu District, Hangz…
Förderung
- Zhejiang Province Traditional Chinese Medicine Science and Technology Project
Zitieren
APA
Deng, Y., Fang, X., Xu, L., Wang, H., Gan, Q., Wang, Q., & Jiang, M. (2024). Integrating network pharmacology and experimental models to investigate the efficacy and mechanism of Tiansha mixture on xerosis. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03201-y
Vancouver
Deng Y, Fang X, Xu L, Wang H, Gan Q, Wang Q, et al. Integrating network pharmacology and experimental models to investigate the efficacy and mechanism of Tiansha mixture on xerosis. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03201-y
BibTeX
@article{Deng2024,
author = {Deng, Yuan and Fang, Xinhua and Xu, Lihua and Wang, Haixia and Gan, Qinting and Wang, Qian and Jiang, Meng},
title = {Integrating network pharmacology and experimental models to investigate the efficacy and mechanism of Tiansha mixture on xerosis},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03201-y}
}
EUVIMED